speb/financial-data huggingface dataset:
DuPont ROE decomposition for TDF (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.0105545655373018
ROE archetype: Standard Business
DuPont ROE decomposition for TDF (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0094387058091456
ROE archetype: Standard Business
DuPont ROE decomposition for TDSA.LS (annual period ending 2022-12-31)
ROE: -5.729722259411696%
Net margin: -1.5910001223200516%
Asset turnover: 0.4909511067150624
Equity multiplier (leverage): 7.335422182105576
EBIT margin: 0.1206411489450495%
Interest burden factor: -10.089463220675945
ROE archetype: Low Return
DuPont ROE decomposition for TDSA.LS (annual period ending 2023-12-31)
ROE: -1.6112732583325813%
Net margin: -0.38957365861669424%
Asset turnover: 0.48793847321345096
Equity multiplier (leverage): 8.476460692734069
EBIT margin: 0.3164552837475187%
Interest burden factor: 9.849258649093906
Tax burden factor: -0.12498954587271054
ROE archetype: Low Return
DuPont ROE decomposition for TDSA.LS (annual period ending 2024-12-31)
ROE: 17.171942441944235%
Net margin: 3.6289609922170203%
Asset turnover: 0.5035609783793891
Equity multiplier (leverage): 9.39690974220314
EBIT margin: 4.408162001566142%
Interest burden factor: 1.166286215978929
Tax burden factor: 0.7058616882465122
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TDSA.LS (annual period ending 2025-12-31)
ROE: 33.69681763147915%
Net margin: 7.380872098130166%
Asset turnover: 0.5396945032311008
Equity multiplier (leverage): 8.459276355284201
EBIT margin: 1.08891842037408%
Interest burden factor: 10.573250065053344
Tax burden factor: 0.6410676051485247
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TE (annual period ending 2022-12-31)
ROE: -13.718552422003341%
Asset turnover: 0
Equity multiplier (leverage): 1.149377818079311
ROE archetype: Low Return
DuPont ROE decomposition for TE (annual period ending 2023-12-31)
ROE: -10.62041874962634%
Asset turnover: 0
Equity multiplier (leverage): 1.1513385683802477
ROE archetype: Low Return
DuPont ROE decomposition for TE (annual period ending 2024-12-31)
ROE: -103.2632794748656%
Net margin: -15300.883752549285%
Asset turnover: 0.0028452184710964197
Equity multiplier (leverage): 2.371995049624191
EBIT margin: -2650.1699524133246%
ROE archetype: Low Return
DuPont ROE decomposition for TE (annual period ending 2025-12-31)
ROE: -131.59911416724208%
Net margin: -48.70070634652686%
Asset turnover: 0.5578344388420188
Equity multiplier (leverage): 4.844092003534745
EBIT margin: -23.796662231313594%
ROE archetype: Low Return
DuPont ROE decomposition for TELA (quarterly period ending 2025-03-31)
ROE: -62.153065165811405%
Net margin: -60.8207343412527%
Asset turnover: 0.23973799691913372
Equity multiplier (leverage): 4.262594493185455
EBIT margin: -56.54427645788337%
ROE archetype: Low Return
DuPont ROE decomposition for TELA (quarterly period ending 2025-06-30)
ROE: -72.6773354817446%
Net margin: -49.13105906817844%
Asset turnover: 0.2789872088847142
Equity multiplier (leverage): 5.302230197385286
EBIT margin: -44.962123087587266%
ROE archetype: Low Return
DuPont ROE decomposition for TELA (quarterly period ending 2025-09-30)
ROE: -160.18992645005122%
Net margin: -41.5824834453091%
Asset turnover: 0.32045165887054305
Equity multiplier (leverage): 12.021599478633274
EBIT margin: -36.512156218280246%
ROE archetype: Low Return
DuPont ROE decomposition for TELA (quarterly period ending 2025-12-31)
ROE: -229.75857687420586%
Net margin: -43.322631654607314%
Asset turnover: 0.2918639208419286
Equity multiplier (leverage): 18.17090216010165
EBIT margin: -31.855862762949833%
ROE archetype: Low Return
DuPont ROE decomposition for TELA (quarterly period ending 2026-03-31)
ROE: -2207.3741007194244%
Net margin: -64.39477412246183%
Asset turnover: 0.25192156448063235
Equity multiplier (leverage): 136.06924460431654
EBIT margin: -55.22850097067003%
ROE archetype: Low Return
DuPont ROE decomposition for TELO (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for TELO (quarterly period ending 2025-06-30)
ROE: -3167.523124357657%
Asset turnover: 0
Equity multiplier (leverage): 4.125988310523964
ROE archetype: Low Return
DuPont ROE decomposition for TELO (quarterly period ending 2025-09-30)
ROE: -29.55000668182823%
Asset turnover: 0
Equity multiplier (leverage): 1.1033699602964024
ROE archetype: Low Return
DuPont ROE decomposition for TELO (quarterly period ending 2025-12-31)
ROE: -31.974624360489827%
Asset turnover: 0
Equity multiplier (leverage): 1.1435541718246323
ROE archetype: Low Return
DuPont ROE decomposition for TELO (quarterly period ending 2026-03-31)
ROE: -18.22331392228987%
Asset turnover: 0
Equity multiplier (leverage): 1.207372635026163
ROE archetype: Low Return
DuPont ROE decomposition for TENX (quarterly period ending 2025-03-31)
ROE: -9.523199531525925%
Asset turnover: 0
Equity multiplier (leverage): 1.0253268796149728
ROE archetype: Low Return
DuPont ROE decomposition for TENX (quarterly period ending 2025-06-30)
ROE: -10.203131393418335%
Asset turnover: 0
Equity multiplier (leverage): 1.0249034667318844
ROE archetype: Low Return
DuPont ROE decomposition for TENX (quarterly period ending 2025-09-30)
ROE: -15.840353611538479%
Asset turnover: 0
Equity multiplier (leverage): 1.045734961737187
ROE archetype: Low Return
DuPont ROE decomposition for TENX (quarterly period ending 2025-12-31)
ROE: -16.080131621154585%
Asset turnover: 0
Equity multiplier (leverage): 1.071165447377407
ROE archetype: Low Return
DuPont ROE decomposition for TENX (quarterly period ending 2026-03-31)
ROE: -14.84300845756813%
Asset turnover: 0
Equity multiplier (leverage): 1.0738655950284044
ROE archetype: Low Return
DuPont ROE decomposition for TEP.L (annual period ending 2022-03-31)
ROE: 17.25275206374378%
Net margin: 3.666093672636762%
Asset turnover: 2.0769947507970414
Equity multiplier (leverage): 2.2657887952211624
EBIT margin: 6.617719263246137%
Interest burden factor: 0.7373715285370653
Tax burden factor: 0.7512921538722251
ROE archetype: Balanced Compounder
DuPont ROE decomposition for TEP.L (annual period ending 2023-03-31)
ROE: 30.424703119514714%
Net margin: 2.7645081530082902%
Asset turnover: 3.833986714739429
Equity multiplier (leverage): 2.8705021096689705
EBIT margin: 4.628751272645%
Interest burden factor: 0.745873665651267
Tax burden factor: 0.8007348983078615
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TEP.L (annual period ending 2024-03-31)
ROE: 31.044756132495788%
Net margin: 3.483689865928182%
Asset turnover: 2.858915188939654
Equity multiplier (leverage): 3.117076747840509
EBIT margin: 6.716684705396564%
Interest burden factor: 0.7336122428118748
Tax burden factor: 0.7069976213461788
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TEP.L (annual period ending 2025-03-31)
ROE: 31.822998100385536%
Net margin: 4.139855376801533%
Asset turnover: 2.6809070574590668
Equity multiplier (leverage): 2.8673068042649126
EBIT margin: 8.432200531402124%
Interest burden factor: 0.68355516558385
Tax burden factor: 0.7182417955808926
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TEP.L (annual period ending 2026-03-31)
ROE: 31.327265015063123%
Net margin: 4.155983054593451%
Asset turnover: 2.543924591872274
Equity multiplier (leverage): 2.9630875198679894
EBIT margin: 8.619530492922156%
Interest burden factor: 0.6752973522204291
Tax burden factor: 0.7139949019330171
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TEP.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.6501316944688322
ROE archetype: Standard Business
DuPont ROE decomposition for TEP.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 2.801806199658287
ROE archetype: Standard Business
DuPont ROE decomposition for TERASOFT.NS (annual period ending 2023-03-31)
ROE: 3.2129861822496837%
Net margin: 2.9728788494826754%
Asset turnover: 0.5909952018006555
Equity multiplier (leverage): 1.8287220087421259
EBIT margin: 22.24289461539913%
Interest burden factor: 0.3337948162231161
Tax burden factor: 0.4004112944221082
ROE archetype: Low Return
DuPont ROE decomposition for TERASOFT.NS (annual period ending 2024-03-31)
ROE: 3.5257477283436534%
Net margin: 4.6335039801142255%
Asset turnover: 0.4144330268813443
Equity multiplier (leverage): 1.8360619755864365
EBIT margin: 8.902317047909332%
Interest burden factor: 0.8146897312821604
Tax burden factor: 0.6388725682203943
ROE archetype: Low Return
DuPont ROE decomposition for TERASOFT.NS (annual period ending 2025-03-31)
ROE: 7.9173146440958355%
Net margin: 8.777978647328494%
Asset turnover: 0.5035636585241304
Equity multiplier (leverage): 1.7911378213455942
EBIT margin: 11.325064635138954%
Interest burden factor: 1.0186633516646357
Tax burden factor: 0.7608922293611348
ROE archetype: Standard Business
DuPont ROE decomposition for TERASOFT.NS (annual period ending 2026-03-31)
ROE: 17.65019160478439%
Net margin: 10.418479171821495%
Asset turnover: 0.8496010443072445
Equity multiplier (leverage): 1.994022520409185
EBIT margin: 15.119895246829069%
Interest burden factor: 0.9023177243958413
Tax burden factor: 0.763652991095072
ROE archetype: Balanced Compounder
DuPont ROE decomposition for TFG.L (annual period ending 2022-12-31)
ROE: -1.1636759108210983%
Asset turnover: -0.005043373007867662
Equity multiplier (leverage): 1.078194671016857
ROE archetype: Low Return
DuPont ROE decomposition for TFG.L (annual period ending 2023-12-31)
ROE: 5.05381543365748%
Net margin: 88.90989287964713%
Asset turnover: 0.05220394736842105
Equity multiplier (leverage): 1.0888447142678057
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for TFG.L (annual period ending 2024-12-31)
ROE: 11.743131501733796%
Net margin: 96.4931506849315%
Asset turnover: 0.10943379255550392
Equity multiplier (leverage): 1.1120798879701255
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for TFG.L (annual period ending 2025-12-31)
ROE: 20.654512512739213%
Net margin: 97.12460063897763%
Asset turnover: 0.1920883729255632
Equity multiplier (leverage): 1.1070943268033064
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for TGM.AX (annual period ending 2021-06-30)
ROE: -50.241712707182316%
Equity multiplier (leverage): 2.22951197053407
ROE archetype: Low Return
DuPont ROE decomposition for TGM.AX (annual period ending 2022-06-30)
ROE: -106.88031757173806%
Equity multiplier (leverage): 2.8673115062399335
ROE archetype: Low Return
DuPont ROE decomposition for TGM.AX (annual period ending 2023-06-30)
ROE: -324.6984179590092%
Equity multiplier (leverage): 9.305565425497162
ROE archetype: Low Return
DuPont ROE decomposition for TH (annual period ending 2022-12-31)
ROE: 36.813594427599114%
Net margin: 14.729324581411795%
Asset turnover: 0.6504696609034024
Equity multiplier (leverage): 3.8423625944126623
EBIT margin: 34.73550006474297%
Interest burden factor: 0.6096853188963508
Tax burden factor: 0.6955102578332972
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TH (annual period ending 2023-12-31)
ROE: 60.08779667700993%
Net margin: 30.819292841833327%
Asset turnover: 0.7688639092000437
Equity multiplier (leverage): 2.5357949612041084
EBIT margin: 42.690309576869026%
Interest burden factor: 0.9340997315112674
Tax burden factor: 0.7728587319243604
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TH (annual period ending 2024-12-31)
ROE: 17.88759226299698%
Net margin: 18.48619625548836%
Asset turnover: 0.54399641722184
Equity multiplier (leverage): 1.7787228659426326
EBIT margin: 28.161761660177287%
Interest burden factor: 0.8534302865390095
Tax burden factor: 0.7691653112444392
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for TH (annual period ending 2025-12-31)
ROE: -9.153119792630994%
Net margin: -11.563615949600011%
Asset turnover: 0.5105738232884467
Equity multiplier (leverage): 1.5503042646423502
EBIT margin: -10.836932961155208%
ROE archetype: Low Return
DuPont ROE decomposition for THEINVEST.NS (annual period ending 2023-03-31)
ROE: 1.791786919523553%
Net margin: 3.9625631813078854%
Asset turnover: 0.2793895780403441
Equity multiplier (leverage): 1.6184525086750807
EBIT margin: 6.046951462307255%
Interest burden factor: 1.235588873098286
Tax burden factor: 0.5303538533446978
ROE archetype: Low Return
DuPont ROE decomposition for THEINVEST.NS (annual period ending 2024-03-31)
ROE: 2.9732699086314622%
Net margin: 6.942049722706573%
Asset turnover: 0.24342049388890036
Equity multiplier (leverage): 1.7595008310369011
EBIT margin: 14.244474897620213%
Interest burden factor: 0.8859761914637687
Tax burden factor: 0.5500716016743776
ROE archetype: Low Return
DuPont ROE decomposition for THEINVEST.NS (annual period ending 2025-03-31)
ROE: 6.297895460598301%
Net margin: 13.010983693454973%
Asset turnover: 0.24527749926626072
Equity multiplier (leverage): 1.9734567151047364
EBIT margin: 22.998413173746%
Interest burden factor: 0.8205284242373474
Tax burden factor: 0.6894751697238478
ROE archetype: Standard Business
DuPont ROE decomposition for THEINVEST.NS (annual period ending 2026-03-31)
ROE: 4.433204693107432%
Net margin: 12.200093553555545%
Asset turnover: 0.21081404704562023
Equity multiplier (leverage): 1.7236737896693346
EBIT margin: 16.670034641525056%
Interest burden factor: 0.9772586405359935
Tax burden factor: 0.7488884622271312
ROE archetype: Low Return
DuPont ROE decomposition for THEMISMED.NS (annual period ending 2022-03-31)
ROE: 25.35086633060673%
Net margin: 18.623015832456026%
Asset turnover: 0.9148336588507424
Equity multiplier (leverage): 1.4879922111639983
EBIT margin: 22.014984106217483%
Interest burden factor: 1.1057022675357957
Tax burden factor: 0.7650563708509165
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for THEMISMED.NS (annual period ending 2023-03-31)
ROE: 17.48914495564418%
Net margin: 16.519138929613447%
Asset turnover: 0.7050502856750793
Equity multiplier (leverage): 1.5016235777335856
EBIT margin: 16.53513521359829%
Interest burden factor: 1.2731717937148086
Tax burden factor: 0.7846801140179467
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for THEMISMED.NS (annual period ending 2024-03-31)
ROE: 12.049106533152582%
Net margin: 11.55604244350725%
Asset turnover: 0.6920539062714258
Equity multiplier (leverage): 1.5066271580090025
EBIT margin: 10.423665090948099%
Interest burden factor: 1.3613015137968714
Tax burden factor: 0.8143935991856776
ROE archetype: Standard Business
DuPont ROE decomposition for THEMISMED.NS (annual period ending 2025-03-31)
ROE: 7.55263675483489%
Net margin: 7.3568795565897505%
Asset turnover: 0.6937443833128374
Equity multiplier (leverage): 1.4798083436738012
EBIT margin: 9.646949680354398%
Interest burden factor: 1.0141975229744755
Tax burden factor: 0.751936362788564
ROE archetype: Standard Business
DuPont ROE decomposition for THEMISMED.NS (annual period ending 2026-03-31)
ROE: 0.2714865060925088%
Net margin: 0.3342435252917947%
Asset turnover: 0.5490828434026387
Equity multiplier (leverage): 1.4792697324903747
EBIT margin: -2.900897189216198%
Tax burden factor: 0.5932475884244374
ROE archetype: Low Return
DuPont ROE decomposition for THG.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 8.323535855238418
ROE archetype: Standard Business
DuPont ROE decomposition for THG.L (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 5.6131721912837556
ROE archetype: Standard Business
DuPont ROE decomposition for THG.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.795461730653685
ROE archetype: Standard Business
DuPont ROE decomposition for THM (annual period ending 2022-12-31)
ROE: -5.061541291710241%
Asset turnover: 0
Equity multiplier (leverage): 1.0047988820219853
ROE archetype: Low Return
DuPont ROE decomposition for THM (annual period ending 2023-12-31)
ROE: -5.88562169983758%
Asset turnover: 0
Equity multiplier (leverage): 1.00445889352429
ROE archetype: Low Return
DuPont ROE decomposition for THM (annual period ending 2024-12-31)
ROE: -6.088040792671367%
Asset turnover: 0
Equity multiplier (leverage): 1.0036535231156014
ROE archetype: Low Return
DuPont ROE decomposition for THM (annual period ending 2025-12-31)
ROE: -8.404600397561273%
Asset turnover: 0
Equity multiplier (leverage): 1.0060518781751937
ROE archetype: Low Return
DuPont ROE decomposition for THOMASCOOK.NS (annual period ending 2023-03-31)
ROE: 0.6192301720946339%
Net margin: 0.20939131137113956%
Asset turnover: 0.8713610083785219
Equity multiplier (leverage): 3.3938709947093733
EBIT margin: 2.3681208290845945%
Interest burden factor: 0.22885402455661666
Tax burden factor: 0.3863636363636364
ROE archetype: Low Return
DuPont ROE decomposition for THOMASCOOK.NS (annual period ending 2024-03-31)
ROE: 14.52367282324457%
Net margin: 3.7591409896256525%
Asset turnover: 1.1833077114301591
Equity multiplier (leverage): 3.2650523402441003
EBIT margin: 4.695771780998944%
Interest burden factor: 1.01854367211953
Tax burden factor: 0.78596277613498
ROE archetype: Standard Business
DuPont ROE decomposition for THOMASCOOK.NS (annual period ending 2025-03-31)
ROE: 11.95843144223368%
Net margin: 3.174492018620148%
Asset turnover: 1.188445889305614
Equity multiplier (leverage): 3.1697175595209686
EBIT margin: 4.113485110392809%
Interest burden factor: 1.1300400215040916
Tax burden factor: 0.6829210275927688
ROE archetype: Standard Business
DuPont ROE decomposition for THOMASCOOK.NS (annual period ending 2026-03-31)
ROE: 8.835343343586294%
Net margin: 2.6253338524940553%
Asset turnover: 1.0665760658233885
Equity multiplier (leverage): 3.155346506419219
EBIT margin: 3.2476122774366325%
Interest burden factor: 1.1983574099875338
Tax burden factor: 0.6745808346591604
ROE archetype: Standard Business
DuPont ROE decomposition for THQ (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.2428211744911182
ROE archetype: Standard Business
DuPont ROE decomposition for THQ (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.2591076598704594
ROE archetype: Standard Business
DuPont ROE decomposition for THQ (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.2926372787711549
ROE archetype: Standard Business
DuPont ROE decomposition for THQ (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 1.3130921826333677
ROE archetype: Standard Business
DuPont ROE decomposition for THR.AX (annual period ending 2021-06-30)
ROE: -17.09318384921602%
Asset turnover: 0
Equity multiplier (leverage): 1.0264846860021122
ROE archetype: Low Return
DuPont ROE decomposition for THR.AX (annual period ending 2022-06-30)
ROE: -8.811042516971918%
Asset turnover: 0
Equity multiplier (leverage): 1.0281375958714596
ROE archetype: Low Return
DuPont ROE decomposition for THR.AX (annual period ending 2023-06-30)
ROE: -3.694450569611671%
Asset turnover: 0
Equity multiplier (leverage): 1.0224261987144803
ROE archetype: Low Return
DuPont ROE decomposition for THRM (quarterly period ending 2025-03-31)
ROE: -0.019798059790140567%
Net margin: -0.03617311094406167%
Asset turnover: 0.26323604459302835
Equity multiplier (leverage): 2.079176771926351
EBIT margin: 6.717742345713204%
Interest burden factor: 0.08766984981700392
Tax burden factor: -0.061420345489443376
ROE archetype: Low Return
DuPont ROE decomposition for THRM (quarterly period ending 2025-06-30)
ROE: 0.07086229910278227%
Net margin: 0.127169479324962%
Asset turnover: 0.27726455077103557
Equity multiplier (leverage): 2.0097313100686116
EBIT margin: 6.962862246394199%
Interest burden factor: 0.09702492629321897
Tax burden factor: 0.1882399368587214
ROE archetype: Low Return
DuPont ROE decomposition for THRM (quarterly period ending 2025-09-30)
ROE: 2.1089192088837287%
Net margin: 3.8640887119704295%
Asset turnover: 0.28210516797825236
Equity multiplier (leverage): 1.9346473460756313
EBIT margin: 7.1972497221288805%
Interest burden factor: 0.7500359143801179
Tax burden factor: 0.7158111472897912
ROE archetype: Low Return
DuPont ROE decomposition for THRM (quarterly period ending 2025-12-31)
ROE: 0.41535983135306215%
Net margin: 0.7803274919798948%
Asset turnover: 0.275608727019286
Equity multiplier (leverage): 1.9313217050194296
EBIT margin: 5.130777349342194%
Interest burden factor: 0.5261201629327902
Tax burden factor: 0.28907384109164813
ROE archetype: Low Return
DuPont ROE decomposition for THRM (quarterly period ending 2026-03-31)
ROE: 0.5871409451465869%
Net margin: 1.0713578152225265%
Asset turnover: 0.2785600145468799
Equity multiplier (leverage): 1.9673836105827354
EBIT margin: 4.565843548231421%
Interest burden factor: 0.42356475300400537
Tax burden factor: 0.55397951142632
ROE archetype: Low Return
DuPont ROE decomposition for THRM (quarterly period ending 2026-06-30)
ROE: 0.6140645795880488%
Net margin: 1.062076190750806%
Asset turnover: 0.2847041455133542
Equity multiplier (leverage): 2.030787975448531
EBIT margin: 4.001528236328773%
Interest burden factor: 0.439800636521948
Tax burden factor: 0.6034953577280174
ROE archetype: Low Return
DuPont ROE decomposition for THS.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.5492943654419933
ROE archetype: Standard Business
DuPont ROE decomposition for THS.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.5310718937420313
ROE archetype: Standard Business
DuPont ROE decomposition for THS.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.4835136211085467
ROE archetype: Standard Business
DuPont ROE decomposition for THS.L (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 1.488824458398438
ROE archetype: Standard Business
DuPont ROE decomposition for THW (annual period ending 2022-09-30)
ROE: -13.830104254992515%
Asset turnover: -0.10506776217196932
Equity multiplier (leverage): 1.2830273246354211
ROE archetype: Low Return
DuPont ROE decomposition for THW (annual period ending 2023-09-30)
ROE: 8.346009227910887%
Net margin: 96.42309081078918%
Asset turnover: 0.0676921462855513
Equity multiplier (leverage): 1.2786730967278213
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for THW (annual period ending 2024-09-30)
ROE: 19.900057255588983%
Net margin: 98.80592972119338%
Asset turnover: 0.159607005681172
Equity multiplier (leverage): 1.2618838055422914
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for THW (annual period ending 2025-09-30)
ROE: 11.036891054627782%
Net margin: 98.44783218325485%
Asset turnover: 0.08994420533607596
Equity multiplier (leverage): 1.2464286100898678
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for TIE.V (quarterly period ending 2024-12-31)
ROE: -101.20834513357877%
Asset turnover: -0.0028721876495931067
Equity multiplier (leverage): 1.1832342112715946
ROE archetype: Low Return
DuPont ROE decomposition for TIE.V (quarterly period ending 2025-03-31)
ROE: -21.148225469728605%
Asset turnover: -0.06235945338176787
Equity multiplier (leverage): 1.2068893528183717
ROE archetype: Low Return
DuPont ROE decomposition for TIE.V (quarterly period ending 2025-06-30)
ROE: 29.274880991918522%
Asset turnover: -0.030572938086346955
Equity multiplier (leverage): 1.1885633020804063
Interest burden factor: 0.9996673320026613
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for TIE.V (quarterly period ending 2025-09-30)
ROE: 25.959708190141516%
Net margin: 5342.857142857143%
Asset turnover: 0.004350379274593536
Equity multiplier (leverage): 1.1168609920906944
EBIT margin: 5342.857142857143%
Interest burden factor: 1
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for TIE.V (quarterly period ending 2025-12-31)
ROE: -16.880776107481935%
Net margin: -3707.352941176471%
Asset turnover: 0.004060299659737266
Equity multiplier (leverage): 1.121425404046012
EBIT margin: -3707.352941176471%
ROE archetype: Low Return
DuPont ROE decomposition for TIE.V (quarterly period ending 2026-03-31)
ROE: 20.412827479934943%
Asset turnover: -0.014411189322300694
Equity multiplier (leverage): 1.1258095731926825
Interest burden factor: 1.0031766200762389
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for TIP.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.5392160309368956
ROE archetype: Standard Business
DuPont ROE decomposition for TITC.BR (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.7991524313611358
ROE archetype: Standard Business
DuPont ROE decomposition for TITC.BR (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.8215087722414072
ROE archetype: Standard Business
DuPont ROE decomposition for TITC.BR (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.6777656308038724
ROE archetype: Standard Business
DuPont ROE decomposition for TITN (quarterly period ending 2025-01-31)
ROE: -7.10692633008564%
Net margin: -5.74295782988254%
Asset turnover: 0.4189349360341974
Equity multiplier (leverage): 2.9539259734528405
EBIT margin: -6.0123275809885754%
ROE archetype: Low Return
DuPont ROE decomposition for TITN (quarterly period ending 2025-04-30)
ROE: -2.165440365520561%
Net margin: -2.221638938243687%
Asset turnover: 0.329123870833766
Equity multiplier (leverage): 2.961511117889729
EBIT margin: -0.9201865611371346%
ROE archetype: Low Return
DuPont ROE decomposition for TITN (quarterly period ending 2025-07-31)
ROE: -0.987014995225315%
Net margin: -1.098044382953959%
Asset turnover: 0.29732380498684713
Equity multiplier (leverage): 3.023250783237524
EBIT margin: 0.18026228620160828%
Interest burden factor: -8.361421319796955
ROE archetype: Low Return
DuPont ROE decomposition for TITN (quarterly period ending 2025-10-31)
ROE: 0.19591665855798474%
Net margin: 0.18587764348109417%
Asset turnover: 0.3534174027815629
Equity multiplier (leverage): 2.9823339757589933
EBIT margin: 1.6356611999813813%
Interest burden factor: 0.2663631189527604
Tax burden factor: 0.42663817663817666
ROE archetype: Low Return
DuPont ROE decomposition for TITN (quarterly period ending 2026-01-31)
ROE: -6.068843315513405%
Net margin: -5.580930278491014%
Asset turnover: 0.3827577571665493
Equity multiplier (leverage): 2.8410267768750357
EBIT margin: -1.348477928105866%
ROE archetype: Low Return
DuPont ROE decomposition for TITN (quarterly period ending 2026-04-30)
ROE: -2.2021775654033298%
Net margin: -2.41509549543341%
Asset turnover: 0.32328537717896016
Equity multiplier (leverage): 2.820538063755973
EBIT margin: -0.9761074771096192%
ROE archetype: Low Return
DuPont ROE decomposition for TJX.DE (quarterly period ending 2025-04-30)
ROE: 12.183935081735859%
Net margin: 7.901761879337961%
Asset turnover: 0.4115449808525331
Equity multiplier (leverage): 3.7466776431847584
EBIT margin: 10.03737319807795%
Interest burden factor: 1.0227963525835866
Tax burden factor: 0.7696879643387816
ROE archetype: Standard Business
DuPont ROE decomposition for TJX.DE (quarterly period ending 2025-07-31)
ROE: 14.312856238125397%
Net margin: 8.631345045482952%
Asset turnover: 0.444866626507885
Equity multiplier (leverage): 3.7275030226265184
EBIT margin: 11.249218804249706%
Interest burden factor: 1.0166666666666666
Tax burden factor: 0.7547055251973285
ROE archetype: Standard Business
DuPont ROE decomposition for TJX.DE (quarterly period ending 2025-10-31)
ROE: 15.824417009602195%
Net margin: 9.538929681815175%
Asset turnover: 0.4441408487946763
Equity multiplier (leverage): 3.7351440329218106
EBIT margin: 12.489250512667857%
Interest burden factor: 1.0148305084745763
Tax burden factor: 0.7526096033402923
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TJX.DE (quarterly period ending 2026-01-31)
ROE: 18.139035244769552%
Net margin: 9.992673166882714%
Asset turnover: 0.5001197942357832
Equity multiplier (leverage): 3.6295974218630107
EBIT margin: 13.267203967761935%
Interest burden factor: 1.0152931180968565
Tax burden factor: 0.7418410041841004
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TJX.DE (quarterly period ending 2026-04-30)
ROE: 12.936434710824066%
Net margin: 9.299727710675137%
Asset turnover: 0.398275981925617
Equity multiplier (leverage): 3.49269169135143
EBIT margin: 11.771276967115828%
Interest burden factor: 1.0207591933570581
Tax burden factor: 0.7739686228936665
ROE archetype: Standard Business
DuPont ROE decomposition for TK.V (quarterly period ending 2025-03-31)
ROE: -0.547054036942964%
Asset turnover: 0
Equity multiplier (leverage): 1.0043302389932713
ROE archetype: Low Return
DuPont ROE decomposition for TK.V (quarterly period ending 2025-06-30)
ROE: -0.3907733137914925%
Asset turnover: 0
Equity multiplier (leverage): 1.0040675099825962
ROE archetype: Low Return
DuPont ROE decomposition for TK.V (quarterly period ending 2025-09-30)
ROE: -0.22847421246842567%
Asset turnover: 0
Equity multiplier (leverage): 1.007031272810904
ROE archetype: Low Return
DuPont ROE decomposition for TK.V (quarterly period ending 2025-12-31)
ROE: -0.8165737744132512%
Asset turnover: 0
Equity multiplier (leverage): 1.0081281061734293
ROE archetype: Low Return
DuPont ROE decomposition for TK.V (quarterly period ending 2026-03-31)
ROE: -0.8484126668448413%
Asset turnover: 0
Equity multiplier (leverage): 1.00657456502892
ROE archetype: Low Return
DuPont ROE decomposition for TLRY.TO (quarterly period ending 2025-02-28)
ROE: -29.215614652735294%
Net margin: -382.15281542870423%
Asset turnover: 0.06070148033613603
Equity multiplier (leverage): 1.2594434779133141
EBIT margin: -15.201185036015803%
ROE archetype: Low Return
DuPont ROE decomposition for TLRY.TO (quarterly period ending 2025-05-31)
ROE: -62.16557533369189%
Net margin: -564.6758857193756%
Asset turnover: 0.08416366794437123
Equity multiplier (leverage): 1.308055169039985
EBIT margin: -5.639209922729195%
ROE archetype: Low Return
DuPont ROE decomposition for TLRY.TO (quarterly period ending 2025-08-31)
ROE: 0.10088553299239082%
Net margin: 0.7221922568388696%
Asset turnover: 0.10116076852824188
Equity multiplier (leverage): 1.3809054543023613
EBIT margin: -5.189951360614031%
ROE archetype: Low Return
DuPont ROE decomposition for TLRY.TO (quarterly period ending 2025-11-30)
ROE: -2.8066102884700976%
Net margin: -17.857025593879797%
Asset turnover: 0.11528773327646735
Equity multiplier (leverage): 1.3632951554378145
EBIT margin: -8.212532628502947%
ROE archetype: Low Return
DuPont ROE decomposition for TLRY.TO (quarterly period ending 2026-02-28)
ROE: -1.66062487301734%
Net margin: -11.081443095232867%
Asset turnover: 0.1103128095542637
Equity multiplier (leverage): 1.3584675604824688
EBIT margin: -8.725763597637295%
ROE archetype: Low Return
DuPont ROE decomposition for TLSA (annual period ending 2022-12-31)
ROE: -78.67252567574474%
Asset turnover: 0
Equity multiplier (leverage): 1.3528690409279036
ROE archetype: Low Return
DuPont ROE decomposition for TLSA (annual period ending 2023-12-31)
ROE: -146.42552815944578%
Asset turnover: 0
Equity multiplier (leverage): 1.5471478068624953
ROE archetype: Low Return
DuPont ROE decomposition for TLSA (annual period ending 2024-12-31)
ROE: -248.64610306915145%
Asset turnover: 0
Equity multiplier (leverage): 2.4755858131341
ROE archetype: Low Return
DuPont ROE decomposition for TLSA (annual period ending 2025-12-31)
ROE: -998.2127383015596%
Asset turnover: 0
Equity multiplier (leverage): 5.939314341421143
ROE archetype: Low Return
DuPont ROE decomposition for TLSI (annual period ending 2022-12-31)
Net margin: -380.6017099532183%
Asset turnover: 0.5636735621732212
EBIT margin: -293.91030811421194%
ROE archetype: Standard Business
DuPont ROE decomposition for TLSI (annual period ending 2023-12-31)
Net margin: -320.69040030252285%
Asset turnover: 0.7945828772562402
EBIT margin: -294.28447949867643%
ROE archetype: Standard Business
DuPont ROE decomposition for TLSI (annual period ending 2024-12-31)
Net margin: -102.08623560191634%
Asset turnover: 1.2119253021474603
EBIT margin: -122.88063606401414%
ROE archetype: Standard Business
DuPont ROE decomposition for TLSI (annual period ending 2025-12-31)
Net margin: -86.87958184757812%
Asset turnover: 1.5227479680280598
EBIT margin: -59.679741312484765%
ROE archetype: Standard Business
DuPont ROE decomposition for TM5.DE (annual period ending 2022-12-31)
ROE: 3.7182726541862867%
Net margin: 3.2549546945495216%
Asset turnover: 0.376510613330305
Equity multiplier (leverage): 3.0340243482255658
EBIT margin: 10.188385215719295%
Interest burden factor: 0.3880597014925373
Tax burden factor: 0.8232676414494596
ROE archetype: Low Return
DuPont ROE decomposition for TM5.DE (annual period ending 2023-12-31)
ROE: 12.379159193575994%
Net margin: 10.587082155859365%
Asset turnover: 0.3749606224046585
Equity multiplier (leverage): 3.1183811983240433
EBIT margin: 18.128007332162223%
Interest burden factor: 0.7723474475107085
Tax burden factor: 0.7561596508773525
ROE archetype: Standard Business
DuPont ROE decomposition for TM5.DE (annual period ending 2024-12-31)
ROE: 17.933510470044915%
Net margin: 13.92997542997543%
Asset turnover: 0.39161256335439737
Equity multiplier (leverage): 3.287443853988739
EBIT margin: 22.125307125307124%
Interest burden factor: 0.8168795113825652
Tax burden factor: 0.7707313757476889
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TM5.DE (annual period ending 2025-12-31)
ROE: 18.177007540679984%
Net margin: 12.447202436897712%
Asset turnover: 0.4133619801906046
Equity multiplier (leverage): 3.5328085725625082
EBIT margin: 21.01371321156394%
Interest burden factor: 0.7695748235167322
Tax burden factor: 0.7696939990196765
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TMCV.NS (quarterly period ending 2024-12-31)
Net margin: 7.2471519495106165%
EBIT margin: 6.434187302775846%
Interest burden factor: 1.2726517040731504
Tax burden factor: 0.8850424559111693
ROE archetype: Standard Business
DuPont ROE decomposition for TMCV.NS (quarterly period ending 2025-03-31)
ROE: 12.72192157979683%
Net margin: 6.178247037668864%
Asset turnover: 0.4629356897398134
Equity multiplier (leverage): 4.448020506978069
EBIT margin: 7.289409378025728%
Interest burden factor: 1.0069576217583807
Tax burden factor: 0.8417085427135679
ROE archetype: Standard Business
DuPont ROE decomposition for TMCV.NS (quarterly period ending 2025-12-31)
Net margin: 3.244064053009387%
EBIT margin: 8.61402540033131%
Interest burden factor: 0.49412393162393164
Tax burden factor: 0.7621621621621623
ROE archetype: Standard Business
DuPont ROE decomposition for TMCV.NS (quarterly period ending 2026-03-31)
ROE: 14.080414637977071%
Net margin: 6.903056903056902%
Asset turnover: 0.49654935097210806
Equity multiplier (leverage): 4.107821580021989
EBIT margin: 9.736659736659735%
Interest burden factor: 1.037168841439304
Tax burden factor: 0.6835684330918795
ROE archetype: Standard Business
DuPont ROE decomposition for TMHC (quarterly period ending 2025-03-31)
ROE: 3.5875810152002745%
Net margin: 11.272619103500544%
Asset turnover: 0.20204530458237568
Equity multiplier (leverage): 1.5751725045505482
EBIT margin: 15.118519381926024%
Interest burden factor: 0.9718088260945403
Tax burden factor: 0.7672461759923035
ROE archetype: Low Return
DuPont ROE decomposition for TMHC (quarterly period ending 2025-06-30)
ROE: 3.2622339390511463%
Net margin: 9.654100597516342%
Asset turnover: 0.21556618789969956
Equity multiplier (leverage): 1.5675544672472446
EBIT margin: 14.011536548000809%
Interest burden factor: 0.9255354305241102
Tax burden factor: 0.744445668400041
ROE archetype: Low Return
DuPont ROE decomposition for TMHC (quarterly period ending 2025-09-30)
ROE: 3.336510986157341%
Net margin: 9.755500534176054%
Asset turnover: 0.2197010787807909
Equity multiplier (leverage): 1.5567211029085437
EBIT margin: 14.119998034117604%
Interest burden factor: 0.9205021627466883
Tax burden factor: 0.75056810881257
ROE archetype: Low Return
DuPont ROE decomposition for TMHC (quarterly period ending 2025-12-31)
ROE: 2.8319944887598782%
Net margin: 8.43458878664914%
Asset turnover: 0.21573095217313507
Equity multiplier (leverage): 1.5563813904815331
EBIT margin: 12.773761216208493%
Interest burden factor: 0.8494163003396681
Tax burden factor: 0.7773641886434667
ROE archetype: Low Return
DuPont ROE decomposition for TMHC (quarterly period ending 2026-03-31)
ROE: 1.5995135315366351%
Net margin: 7.240255152506106%
Asset turnover: 0.14146929422417245
Equity multiplier (leverage): 1.5616074068582275
EBIT margin: 10.22217704377215%
Interest burden factor: 0.9216522910480919
Tax burden factor: 0.7684991046968979
ROE archetype: Low Return
DuPont ROE decomposition for TNDM (annual period ending 2022-12-31)
ROE: -21.501226284075127%
Net margin: -11.806289681821529%
Asset turnover: 0.7610452276580688
Equity multiplier (leverage): 2.3929814273082894
EBIT margin: -11.588371190326715%
ROE archetype: Low Return
DuPont ROE decomposition for TNDM (annual period ending 2023-12-31)
ROE: -59.080998807026205%
Net margin: -29.772053100232977%
Asset turnover: 0.7456886084520976
Equity multiplier (leverage): 2.6612246360368323
EBIT margin: -31.19224092505463%
ROE archetype: Low Return
DuPont ROE decomposition for TNDM (annual period ending 2024-12-31)
ROE: -33.299811003415805%
Net margin: -10.213219911019216%
Asset turnover: 0.9792169622083032
Equity multiplier (leverage): 3.329662060236159
EBIT margin: -10.54314866044886%
ROE archetype: Low Return
DuPont ROE decomposition for TNDM (annual period ending 2025-12-31)
ROE: -97.88460986735778%
Net margin: -20.173720061178475%
Asset turnover: 1.0977417418067148
Equity multiplier (leverage): 4.420060822247937
EBIT margin: -16.487638164015074%
ROE archetype: Low Return
DuPont ROE decomposition for TNGX (annual period ending 2022-12-31)
ROE: -43.361285253892156%
Net margin: -435.14078841512475%
Asset turnover: 0.056956950076752125
Equity multiplier (leverage): 1.7495470506180955
EBIT margin: -446.78600160901044%
ROE archetype: Low Return
DuPont ROE decomposition for TNGX (annual period ending 2023-12-31)
ROE: -40.48835617528612%
Net margin: -278.5446382128289%
Asset turnover: 0.08706886585454515
Equity multiplier (leverage): 1.6694463015137768
EBIT margin: -312.5715224354587%
ROE archetype: Low Return
DuPont ROE decomposition for TNGX (annual period ending 2024-12-31)
ROE: -57.5761391880696%
Net margin: -309.7340084147472%
Asset turnover: 0.11701126055024692
Equity multiplier (leverage): 1.5886418116542391
EBIT margin: -346.0861917326297%
ROE archetype: Low Return
DuPont ROE decomposition for TNGX (annual period ending 2025-12-31)
ROE: -37.2346507945816%
Net margin: -162.85265452680176%
Asset turnover: 0.1744562922444916
Equity multiplier (leverage): 1.3105868468891104
EBIT margin: -178.39349833290586%
ROE archetype: Low Return
DuPont ROE decomposition for TNMG (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.5523483563236327
ROE archetype: Standard Business
DuPont ROE decomposition for TNMG (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 54.40271520812815
ROE archetype: Standard Business
DuPont ROE decomposition for TNYA (annual period ending 2022-12-31)
ROE: -50.812323318650975%
Asset turnover: 0
Equity multiplier (leverage): 1.1461483465912827
ROE archetype: Low Return
DuPont ROE decomposition for TNYA (annual period ending 2023-12-31)
ROE: -64.82967607105539%
Asset turnover: 0
Equity multiplier (leverage): 1.1741379310344828
ROE archetype: Low Return
DuPont ROE decomposition for TNYA (annual period ending 2024-12-31)
ROE: -95.6862036008576%
Asset turnover: 0
Equity multiplier (leverage): 1.250462807497912
ROE archetype: Low Return
DuPont ROE decomposition for TNYA (annual period ending 2025-12-31)
ROE: -83.83992152471555%
Asset turnover: 0
Equity multiplier (leverage): 1.2347873162470675
ROE archetype: Low Return
DuPont ROE decomposition for TNZ.TO (quarterly period ending 2025-03-31)
ROE: -5.98901036906656%
Net margin: -30.00226090888537%
Asset turnover: 0.04488156816584769
Equity multiplier (leverage): 4.447675140191135
EBIT margin: -15.538096314718516%
ROE archetype: Low Return
DuPont ROE decomposition for TNZ.TO (quarterly period ending 2025-06-30)
ROE: 102.1672000779875%
Net margin: 313.78518666400487%
Asset turnover: 0.046370927324244915
Equity multiplier (leverage): 7.0215545346919574
EBIT margin: 4.089305916017834%
Interest burden factor: 76.06061838893409
Tax burden factor: 1.0088416052889169
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TNZ.TO (quarterly period ending 2025-09-30)
ROE: 8.237591330366314%
Net margin: 25.885649755322266%
Asset turnover: 0.04258886155099998
Equity multiplier (leverage): 7.472142418919099
EBIT margin: 0.8406876071772136%
Interest burden factor: 20.53855721393035
Tax burden factor: 1.4991824623024286
ROE archetype: Standard Business
DuPont ROE decomposition for TNZ.TO (quarterly period ending 2025-12-31)
ROE: 28.828153668187873%
Net margin: 91.45833333333333%
Asset turnover: 0.04960601193401129
Equity multiplier (leverage): 6.354175886283579
EBIT margin: 11.385204081632654%
Interest burden factor: 5.448129061169617
Tax burden factor: 1.474467064226472
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TNZ.TO (quarterly period ending 2026-03-31)
ROE: -28.77755130935804%
Net margin: -83.33946027863846%
Asset turnover: 0.05132998365997675
Equity multiplier (leverage): 6.727164185454708
EBIT margin: 17.41152816019086%
Interest burden factor: -8.247716304722509
ROE archetype: Low Return
DuPont ROE decomposition for TOPS (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.927378479434981
ROE archetype: Standard Business
DuPont ROE decomposition for TOPS (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 3.2614738837664774
ROE archetype: Standard Business
DuPont ROE decomposition for TORNTPHARM.NS (annual period ending 2023-03-31)
ROE: 20.090608850819695%
Net margin: 13.157975377469041%
Asset turnover: 0.6304146391017763
Equity multiplier (leverage): 2.4220200804443968
EBIT margin: 22.612955411684023%
Interest burden factor: 0.8631508116746572
Tax burden factor: 0.6741321812945279
ROE archetype: Balanced Compounder
DuPont ROE decomposition for TORNTPHARM.NS (annual period ending 2024-03-31)
ROE: 25.189012146119076%
Net margin: 15.681986232178376%
Asset turnover: 0.6969911525229302
Equity multiplier (leverage): 2.3045323148251815
EBIT margin: 24.354047552097978%
Interest burden factor: 0.9143817909693472
Tax burden factor: 0.7042102622751486
ROE archetype: Balanced Compounder
DuPont ROE decomposition for TORNTPHARM.NS (annual period ending 2025-03-31)
ROE: 26.13923922067783%
Net margin: 16.88793655702578%
Asset turnover: 0.7436112676118178
Equity multiplier (leverage): 2.081471135424758
EBIT margin: 25.85486756941837%
Interest burden factor: 0.9134501684859503
Tax burden factor: 0.7150714042524534
ROE archetype: Balanced Compounder
DuPont ROE decomposition for TORNTPHARM.NS (annual period ending 2026-03-31)
ROE: 16.668109090498994%
Net margin: 15.730179400988439%
Asset turnover: 0.45204940735278
Equity multiplier (leverage): 2.3440493687338257
EBIT margin: 25.010997608520036%
Interest burden factor: 0.8349972091076121
Tax burden factor: 0.7532127052876029
ROE archetype: Balanced Compounder
DuPont ROE decomposition for TPET (quarterly period ending 2025-01-31)
ROE: -13.816699071905077%
Net margin: -14932.295036509844%
Asset turnover: 0.0008188579992450976
Equity multiplier (leverage): 1.1299757948520057
EBIT margin: -11243.710139569277%
ROE archetype: Low Return
DuPont ROE decomposition for TPET (quarterly period ending 2025-04-30)
ROE: -13.515444514082686%
Net margin: -6719.745606119204%
Asset turnover: 0.0017248565797430414
Equity multiplier (leverage): 1.1660697046869428
EBIT margin: -3734.171286150144%
ROE archetype: Low Return
DuPont ROE decomposition for TPET (quarterly period ending 2025-07-31)
ROE: -12.127030792501479%
Net margin: -720.7687309961278%
Asset turnover: 0.014356471956059698
Equity multiplier (leverage): 1.171954675372938
EBIT margin: -350.8542321785909%
ROE archetype: Low Return
DuPont ROE decomposition for TPET (quarterly period ending 2025-10-31)
ROE: -23.903695003787135%
Net margin: -1576.8643069045395%
Asset turnover: 0.013125810461586949
Equity multiplier (leverage): 1.15490054776472
EBIT margin: -1458.1454754454307%
ROE archetype: Low Return
DuPont ROE decomposition for TPET (quarterly period ending 2026-01-31)
ROE: -8.619349331815272%
Net margin: -828.7127740541603%
Asset turnover: 0.008925998104468138
Equity multiplier (leverage): 1.1652353701885791
EBIT margin: -658.2963017521462%
ROE archetype: Low Return
DuPont ROE decomposition for TPET (quarterly period ending 2026-04-30)
ROE: -5.85008806004983%
Net margin: -656.5714477784661%
Asset turnover: 0.008348787592334688
Equity multiplier (leverage): 1.067227478586102
EBIT margin: -674.4776886251123%
ROE archetype: Low Return
DuPont ROE decomposition for TPG0.DE (annual period ending 2022-12-31)
ROE: 16.915213979726%
Net margin: 4.735668005033267%
Asset turnover: 2.0005724195272596
Equity multiplier (leverage): 1.7854264749544047
EBIT margin: 5.414550195967193%
Interest burden factor: 0.9648802599316265
Tax burden factor: 0.9064533175745937
ROE archetype: Asset-Light Turnover Play
DuPont ROE decomposition for TPG0.DE (annual period ending 2023-12-31)
ROE: 41.77947086845637%
Net margin: 6.126272513933193%
Asset turnover: 2.368567648737533
Equity multiplier (leverage): 2.879259647580242
EBIT margin: 3.177136477206534%
Interest burden factor: 2.36653267671777
Tax burden factor: 0.8147942119273479
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TPG0.DE (annual period ending 2024-12-31)
ROE: 29.48441899561569%
Net margin: 6.241194406592947%
Asset turnover: 1.6749028516700586
Equity multiplier (leverage): 2.8205593439652925
EBIT margin: 4.430380350019073%
Interest burden factor: 1.5635495418899945
Tax burden factor: 0.9009797949805634
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TPG0.DE (annual period ending 2025-12-31)
ROE: 30.641945990686597%
Net margin: 6.388619356509016%
Asset turnover: 2.1862210830830526
Equity multiplier (leverage): 2.1938920359266088
EBIT margin: 5.611393828726198%
Interest burden factor: 1.2002790739614289
Tax burden factor: 0.9485364583126225
ROE archetype: Balanced Compounder
DuPont ROE decomposition for TPR (quarterly period ending 2025-03-31)
ROE: 13.609586289998662%
Net margin: 12.829736211031175%
Asset turnover: 0.21688429005502177
Equity multiplier (leverage): 4.891016200294551
EBIT margin: 16.010349615044806%
Interest burden factor: 0.9424517146235711
Tax burden factor: 0.850271852781263
ROE archetype: Standard Business
DuPont ROE decomposition for TPR (quarterly period ending 2025-06-30)
ROE: -43.97856778363668%
Net margin: -30.008124419684307%
Asset turnover: 0.24817991315431312
Equity multiplier (leverage): 5.905213471678857
EBIT margin: 15.743964716805941%
Interest burden factor: -2.18945816439366
ROE archetype: Low Return
DuPont ROE decomposition for TPR (quarterly period ending 2025-09-30)
ROE: 43.71271772846576%
Net margin: 16.12108412530799%
Asset turnover: 0.263384786538729
Equity multiplier (leverage): 10.294917680744453
EBIT margin: 19.253783878915876%
Interest burden factor: 0.9710542352224254
Tax burden factor: 0.8622529024160652
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TPR (quarterly period ending 2025-12-31)
ROE: 118.08141369517197%
Net margin: 22.430466751918157%
Asset turnover: 0.3881404961882382
Equity multiplier (leverage): 13.562953613127169
EBIT margin: 28.628516624040923%
Interest burden factor: 0.9730597431602457
Tax burden factor: 0.805192942189069
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TPR (quarterly period ending 2026-03-31)
ROE: 55.739299610894946%
Net margin: 17.90065604498594%
Asset turnover: 0.29552920901390245
Equity multiplier (leverage): 10.536397535667964
EBIT margin: 22.25866916588566%
Interest burden factor: 0.9730994152046784
Tax burden factor: 0.8264423076923076
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for TPVG (annual period ending 2022-12-31)
ROE: -4.779254179168452%
Asset turnover: -0.00937278531107416
Equity multiplier (leverage): 2.4158998904605418
ROE archetype: Low Return
DuPont ROE decomposition for TPVG (annual period ending 2023-12-31)
ROE: -10.39378998389551%
Asset turnover: -0.02715919568888278
Equity multiplier (leverage): 2.601459583475803
ROE archetype: Low Return